{"doi":"10.1007/s12032-014-0088-3","title":"Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy","abstract":null,"journal":"Medical Oncology","year":2014,"id":18812,"datarank":0.6983387549845945,"base_score":2.833213344056216,"endowment":2.833213344056216,"self_citation_contribution":0.42498200160843247,"citation_network_contribution":0.273356753376162,"self_endowment_contribution":0.42498200160843247,"citer_contribution":0.273356753376162,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":6,"citers_with_citation_signal":6,"citers_with_endowment":6,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":129474,"name":"Keita Mori","orcid":null,"position":1,"is_corresponding":false},{"id":129475,"name":"Akira Ono","orcid":"0000-0001-5705-9423","position":2,"is_corresponding":false},{"id":129476,"name":"Hiroaki Akamatsu","orcid":null,"position":3,"is_corresponding":false},{"id":129477,"name":"Tetsuhiko Taira","orcid":null,"position":4,"is_corresponding":false},{"id":129478,"name":"Hirotsugu Kenmotsu","orcid":null,"position":5,"is_corresponding":false},{"id":129479,"name":"Tateaki Naito","orcid":null,"position":6,"is_corresponding":false},{"id":129480,"name":"Kyoichi Kaira","orcid":null,"position":7,"is_corresponding":false},{"id":129481,"name":"Haruyasu Murakami","orcid":null,"position":8,"is_corresponding":false},{"id":129482,"name":"Masahiro Endo","orcid":null,"position":9,"is_corresponding":false},{"id":129483,"name":"Takashi Nakajima","orcid":null,"position":10,"is_corresponding":false},{"id":129484,"name":"Toshiaki Takahashi","orcid":null,"position":11,"is_corresponding":false},{"id":129473,"name":"Hisao Imai","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.833213344056216,"endowment":2.833213344056216,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24961467","pmcid":null,"openalex_id":"https://openalex.org/W2018515503","authors":[],"funders":[],"total_grants":0,"fwci":0.9635,"citation_percentile":0.77371553,"influential_citations":0,"citation_trend":[{"year":2015,"count":1},{"year":2017,"count":3},{"year":2018,"count":4},{"year":2019,"count":1},{"year":2021,"count":5},{"year":2022,"count":1},{"year":2023,"count":1}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://link.springer.com/content/pdf/10.1007/s12032-014-0088-3.pdf","host_type":"publisher"},{"url":"http://link.springer.com/article/10.1007/s12032-014-0088-3/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s12032-014-0088-3","host_type":"publisher"},{"url":"https://doi.org/10.1007/s12032-014-0088-3","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24961467","host_type":"repository"}],"fields_of_study":["Lung Cancer Treatments and Mutations","Lung Cancer Research Studies","Cancer Genomics and Diagnostics","Medicine","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Cisplatin","Disease-Free Survival","Female","Glutamates","Guanine","Humans","Lung Neoplasms","Male","Middle Aged","Neoplasms, Squamous Cell","Pemetrexed","Treatment Outcome"],"mesh_terms":["Pemetrexed","Aged","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Cisplatin","Female","Glutamates","Guanine","Humans","Lung Neoplasms","Male","Middle Aged","Treatment Outcome","Neoplasms, Squamous Cell","Disease-Free Survival"],"keywords":["Pemetrexed","Internal medicine","Oncology","Chemotherapy","Medicine","Lung cancer","Progression-free survival","Surrogate endpoint","Hematology","Cancer","Cisplatin","Performance status"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T23:47:52.555758Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}